Jose Ma. J. Alvir

Pfizer (United States) — United States

Medicine · Health Sciences

22h-index5.7kcitations43works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(17), Health Systems, Economic Evaluations, Quality of Life(7), Obsessive-Compulsive Spectrum Disorders(6), Child and Adolescent Psychosocial and Emotional Development(5), Bipolar Disorder and Treatment(5)

Publications43 total

Suboptimal adherence to prescribed daily growth hormone regimen among medicaid beneficiaries in the United States
Current Medical Research and Opinion·2022· 1 citedOpen Access
Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder
2022
Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency
Current Medical Research and Opinion·2021· 15 citedOpen Access
Sub-Optimal Adherence With Daily Growth Hormones Increases With Each Year of Treatment in a US Commercial Claims Database
Journal of the Endocrine Society·2021· 1 citedOpen Access
The efficacy of cognitive–behavioral therapy for older adults with ADHD: a randomized controlled trial
ADHD Attention Deficit and Hyperactivity Disorders·2018· 34 cited
Patient-Reported Outcomes: Development and Validation
2017· 1 cited
Patient-Reported Outcomes
2013· 126 cited
Patient-Reported Outcomes: Measurement, Implementation and Interpretation
2013· 114 cited
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
BMC Psychiatry·2012· 19 citedOpen Access
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
BMC Psychiatry·2012· 36 citedOpen Access
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
BMC Psychiatry·2011· 14 citedOpen Access
Health Care Utilization and Costs in Patients with Generalized Anxiety Disorder Initiating Add-on Therapy with Benzodiazepines
Health Outcomes Research in Medicine·2011· 2 cited
Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
Journal of Managed Care Pharmacy·2011· 22 citedOpen Access
Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using "Real-World Data"
Journal of Managed Care Pharmacy·2011· 11 citedOpen Access
Outcome Assessment of an Antipsychotic Drug Algorithm: Effects of the Mississippi State Hospital Algorithm Project
Psychiatric Services·2011· 3 cited
Outcome Assessment of an Antipsychotic Drug Algorithm: Effects of the Mississippi State Hospital Algorithm Project
Psychiatric Services·2011· 4 cited
Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve Patients
Neuropsychopharmacology·2011· 52 citedOpen Access
Mining Clinical Trial Data
Knowledge Discovery and Data Mining·2011
Toward characterization and definition of fibromyalgia severity
BMC Musculoskeletal Disorders·2010· 44 citedOpen Access
Efficacy of Meta-Cognitive Therapy for Adult ADHD
American Journal of Psychiatry·2010· 356 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jeffrey A. Lieberman(13), Margaret G. Woerner(10), Robert M. Bilder(10), Delbert G. Robinson(6), Brian Sheitman(5), Miranda Chakos(4), Manzar Ashtari(4), Houwei Wu(4), Joseph C. Cappelleri(4), Demissie Alemayehu(4), John M. Kane(4), Ariel Berger(4), John Edelsberg(4), Gerry Oster(4), Handan Gündüz(4), A. Koreen(3), Todd Lencz(3), Andrew G. Bushmakin(3), Kafi N. Sanders(3), Jane Loftus(3)